mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.03 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.03 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.03 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.04 |